A 79-year-old man may have been in a state of paranoia or confusion from cancer treatment or his impending death when police say he attacked his wife with a knife and hammer last month in their ...

Akeso (SEHK:9926) reported long term survival data from a Phase II study of cadonilimab in advanced cervical cancer, highlighting durable benefits in a setting with limited treatment options. The ...

Ipilimumab-nivolumab also linked with better survival but more toxicity in small study ...

Ever-busy global pharmaceutical company Bristol Myers Squibb (NYSE: BMY) had quite an active February. Since much of the news ...

Pfizer PFE faces several near-term challenges like declining COVID sales, the upcoming loss of exclusivity (“LOE”) cliff and U.S. Medicare Part D headwinds. These headwinds can hurt its sales and ...

Antonio Ocejo, MD, discusses supportive care implications from new data comparing ipilimumab/nivolumab in older vs younger ...

Many cancer treatments were developed for adult physiology, not pediatric biology, resulting in disproportionate long-term ...

Iron is essential to biological function, and iron-based nanomaterials may become valuable tools in the long-term effort to ...

Sylvester Comprehensive Cancer Center, part of the University of Miami Health System, has sponsored PanCAN PurpleStride for ...

Cells in our immune system are best known for providing security against external invaders such as bacteria and viruses. These immune cells also guard against internal threats, including cancerous ...

Long-term results from a phase 2 study presented at the 27th European Congress on Gynaecological Oncology (ESGO 2026) in Hong ...

But the FDA’s decision does not preclude CMS from determining that the higher dose is not reasonable and necessary — ...